Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 1197-18-8
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: D/P,L/C,D/A,T/T,MoneyGram,Western Union
Supply Ability: G,KG,TON
CAS NO:: |
1197-18-8 |
Appearance:: |
White Crystalline Powder |
Molecular Formula:: |
C8H15NO2 |
Molecular Weight:: |
157.21000 |
EINECS NO:: |
214-818-2 |
MDL NO:: |
MFCD00001466 |
CAS NO:: |
1197-18-8 |
Appearance:: |
White Crystalline Powder |
Molecular Formula:: |
C8H15NO2 |
Molecular Weight:: |
157.21000 |
EINECS NO:: |
214-818-2 |
MDL NO:: |
MFCD00001466 |
Product Description:
Product Name: Tranexamic acid CAS NO: 1197-18-8
Synonyms:
Tranexamic acid;
Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans-;
trans-4-(Aminomethyl)cyclohexanecarboxylic acid;
Chemical & Physical Properties:
Appearance: White crystalline powder
Assay :≥99.00%
Density: 1.096g/cm3
Boiling Point: 300.201℃ at 760 mmHg
Melting Point: 300℃
Flash Point: 135.357℃
Refractive Index: 1.497
Stability: Stable at room temperature in closed containers under normal storage and handling conditions.
Storage Condition: Refrigerator
Vapor Pressure: 0mmHg at 25℃
Safety Information:
Hazard Class: 3
Safety Statements: S26; S36; S37/39
HS Code: 2922499990
WGK Germany: 2
Packing Group: II
RIDADR: UN 1993 3/PG 2
Risk Statements: R36/37/38
Hazard Code: Xi
Tranexamic acid (TXA) is a medication used to treat or prevent excessive blood loss from trauma, surgery, and in various medical conditions including hemophilia and heavy menstrual bleeding. It comes in oral and intravenous forms.
Side effects are uncommon and include gastrointestinal effects, dizziness, fatigue, headache, and hypersensitivity reactions. The medication needs to be used cautiously in people with kidney disease and who are at a high risk for blood clots. Tranexamic is safe to use in pregnant women. However, caution should be used in lactating women. It is an antifibrinolytic.
It was discovered in 1962 by Utako Okamoto and has been on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.